Evaluation of spleen glucose metabolism using 18F-FDG PET/CT in patients with febrile autoimmune disease

Journal of Nuclear Medicine

Volumn 58, Issue 3, 2017, Pages 507-513

  Ahn, Sung Soo ^a   Hwang, Sang Hyun ^b   Jung, Seung Min ^a   Lee, Sang Won ^a   Park, Yong Beom ^a   Yun, Mijin ^b   Song, Jason Jungsik ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

18F FDG PET CT; Autoimmune disease; Bone marrow; Immunometabolism; Spleen

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; FERRITIN; FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; ADULT ONSET STILL DISEASE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE DISEASE; BEHCET DISEASE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEBRILE AUTOIMMUNE DISEASE; FEMALE; FERRITIN BLOOD LEVEL; FEVER; GLUCOSE METABOLISM; HEMOPHAGOCYTIC SYNDROME; HOSPITAL ADMISSION; HOSPITAL MORTALITY; HUMAN; IMMUNOGLOBULIN G4 RELATED DISEASE; INFECTION; KIKUCHI DISEASE; LIVER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MONOCYTE; MYOSITIS; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SOUTH KOREA; SPLEEN; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; VASCULITIS; ADOLESCENT; AGED; ANTIBODY SPECIFICITY; COMPLICATION; DIAGNOSTIC IMAGING; FEVER OF UNKNOWN ORIGIN; METABOLIC CLEARANCE RATE; METABOLISM; MOLECULAR IMAGING; PROCEDURES; REPRODUCIBILITY; TISSUE DISTRIBUTION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AUTOIMMUNE DISEASES; FEMALE; FEVER OF UNKNOWN ORIGIN; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MOLECULAR IMAGING; ORGAN SPECIFICITY; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPLEEN; TISSUE DISTRIBUTION; YOUNG ADULT;

EID: 85014836517     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.116.180729     Document Type: Article

References (23)

1. Basu S, Kwee TC, Surti S, Akin EA, Yoo D, Alavi A. Fundamentals of PET and PET/CT imaging. Ann N Y Acad Sci. 2011;1228:1-18
2. Liu Y, Ghesani NV, Zuckier LS. Physiology and pathophysiology of incidental findings detected on FDG-PET scintigraphy. Semin Nucl Med. 2010;40:294-315
3. Oh JR, Song HC, Kang SR, et al. The clinical usefulness of 18F-FDG PET/CT in patients with systemic autoimmune disease. Nucl Med Mol Imaging. 2011;45:177-184
4. Hess S, Hansson SH, Pedersen KT, Basu S, Hoilund-Carlsen PF. FDG-PET/CT in infectious and inflammatory diseases. PET Clin. 2014;9:497-519
5. Cunha BA, Lortholary O, Cunha CB. Fever of unknown origin: a clinical approach. Am J Med. 2015;128:1138.e1-1138.e15
6. MacIver NJ, Michalek RD, Rathmell JC. Metabolic regulation of T lymphocytes. Annu Rev Immunol. 2013;31:259-283
7. Yang Z, Matteson EL, Goronzy JJ, Weyand CM. T-cell metabolism in autoimmune disease. Arthritis Res Ther. 2015;17:29
8. Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol. 2005;5:606-616
9. Mathis D, Shoelson SE. Immunometabolism: an emerging frontier. Nat Rev Immunol. 2011;11:81
10. Yin Y, Choi SC, Xu Z, et al. Normalization of CD41 T cell metabolism reverses lupus. Sci Transl Med. 2015;7:274ra18
11. Everts B, Pearce EJ. Metabolic control of dendritic cell activation and function: recent advances and clinical implications. Front Immunol. 2014;5:203
12. Park BV, Pan F. Metabolic regulation of T cell differentiation and function. Mol Immunol. 2015;68:497-506
13. Yin Y, Choi SC, Xu Z, et al. Glucose oxidation is critical for CD41 T cell activation in a mouse model of systemic lupus erythematosus. J Immunol. 2016;196:80-90
14. Wang H, Li T, Chen S, Gu Y, Ye S. Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-ofconcept trial of metformin. Arthritis Rheumatol. 2015;67:3190-3200
15. Pak K, Kim SJ, Kim IJ, et al. Splenic FDG uptake predicts poor prognosis in patients with unresectable cholangiocarcinoma. Nuklearmedizin. 2014;53:26-31
16. Dong A, Wang Y, Lu J, Zuo C. Enhanced CT and FDG PET/CT findings of splenic hamartoma. Clin Nucl Med. 2014;39:968-971
17. Zhao E, Xu H, Wang L, et al. Bone marrow and the control of immunity. Cell Mol Immunol. 2012;9:11-19
18. Bronte V, Pittet MJ. The spleen in local and systemic regulation of immunity. Immunity. 2013;39:806-818
19. Zandman-Goddard G, Shoenfeld Y. Ferritin in autoimmune diseases. Autoimmun Rev. 2007;6:457-463
20. Israel O, Keidar Z. PET/CT imaging in infectious conditions. Ann N Y Acad Sci. 2011;1228:150-166
21. Glaudemans AW, Signore A. FDG-PET/CT in infections: the imaging method of choice Eur J Nucl Med Mol Imaging. 2010;37:1986-1991
22. Okamura K, Yonemoto Y, Arisaka Y, et al. The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT. Rheumatology (Oxford). 2012;51:1484-1491
23. Dellavedova L, Carletto M, Faggioli P, et al. The prognostic value of baseline 18FFDG PET/CT in steroid-naive large-vessel vasculitis: introduction of volume-based parameters. Eur J Nucl Med Mol Imaging. 2016;43:340-348.